Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
ADC Therapeutics SA
ADC Therapeutics SA logo

ADCT - ADC Therapeutics SA Share News

$23.46 0.7  3.1%

Last Trade - 08/03/21

Sector
Healthcare
RiskRating
Highly Speculative
Size
Mid Cap
Style
Sucker Stock
Market Cap £1.26bn
Enterprise Value £932.7m
Revenue £n/a
Position in Universe 2282nd / 6647
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions ADCT Dividends
All News
All News Reuters News Company Announcements
BRIEF-ADC Therapeutics Enters Into Agreement To Jointly Form New Co With Overland Pharmaceuticals
15th Dec '20 News
BRIEF-Adc Therapeutics SA says Lonca Lotis 2 Subgroup Data Include Updated Median Duration Of Response Of 12.58 Months
7th Dec '20 News
BUZZ-ADC Therapeutics: Up as FDA accepts marketing application for lead cancer drug
20th Nov '20 News
BRIEF-ADC Therapeutics Announces FDA Accepts Biologics License Application And Grants Priority Review For Loncastuximab Tesirine For Treatment Of Relapsed Or Refractory Diffuse Large B-Cell Lymphoma
20th Nov '20 News
BRIEF-ADC Therapeutics Announces Pricing Of Public Offering
24th Sep '20 News
BRIEF-ADC Therapeutics Announces Proposed Public Offering
21st Sep '20 News
BRIEF-Adc Therapeutics SA Files For Secondary Offering Of Up To 5.5 Mln Common Shares - SEC Filing
21st Sep '20 News
Swiss stocks - Factors to watch on September 15
15th Sep '20 News
BRIEF-Hans-Peter Wild Reports 12.1% Stake In ADC Therapeutics SA
14th Sep '20 News
BUZZ-Gilead, Merck interest in 'guided missile' treatment boosts cancer drug developers
14th Sep '20 News
BRIEF-ADC Therapeutics Says U.S. FDA Lifts Partial Clinical Hold On Phase 2 Trial Of Camidanlumab Tesirine
6th Jul '20 News
BRIEF-ADC Therapeutics Announces Loncastuximab Tesirine Clinical Data To Be Presented At The Virtual 25Th EHA Annual Congress
21st May '20 News
Avacta Group PLC - Director Appointment
21st Jan '20 Annoucement
LIVE MARKETS U.S.-Trio of biotechs cross finish line, ADC falls short amid IPO anxiety
3rd Oct '19 News
Biotechnology firm ADC pulls listing amid latest IPO market jitters
3rd Oct '19 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.